The Johnson & Johnson Vaccine Production Mix-up- The Message of Stepped-Up Quality Monitoring and Controls
The Supply Chain Matters blog provides commentary on last week’s revelation of a COVID-19 vaccine production facility’s snafu in producing the Johnson & Johnson vaccine. The commentary addresses what mitigation actions the industry needs to undertake to insure the quality needs of COVID-19 vaccines produced at such volumes.
The Supply Chain Matters blog features a summary capsule of developments directly relative to the ongoing COVID-19 pandemic and its implications for multi-industry supply chains.
The Supply Chain Matters blog reflects on last week’s White House COVID Response Task Force briefing televised nationally where the long awaited voice of the end-to-end supply chain made its presence.
In this abbreviated Supply Chain Matters COVID-19 Healthcare Supply Chain Disruption News Capsule we address the latest developments related to current concerns related to global availability of COVID-19 vaccine supply.
The Supply Chain Matters blog provides its January 5, 2021 bi-weekly capsule of COVID-19 coronavirus news reports that have implications for industry supply chains. This capsule is provided to assist industry supply chain management teams in efforts to keep updated on noteworthy developments.